Friday, April 07, 2006
Celebrex May Have Colon Cancer Protecting Qualities (Vioxx celebrex)
Celebrex May Have Colon Cancer Protecting Qualities
New research indicates that controversial Cox-2 inhibitors may protect patients from developing colon cancer, especially in high-risk individuals. Celebrex is a Cox-2 inhibitor. There has been a great deal of controversy surrounding Cox-2 inhibitors because of their cardiovascular risks. Cox-2 inhibitors are anti-inflammatory drugs (used for pain relief)... click link for more info.
Source: www.medicalnewstoday.com
Less breast cancer in COX-2 users: study
Patients who took prescription pain relievers known as COX-2 inhibitors were less likely to develop breast cancer than others who did not have a history of taking the drugs, a study released on Tuesday said.
Source: news.yahoo.com
Study finds less breast cancer in COX-2 drug users
Women who took prescription pain relievers known as COX-2 inhibitors for at least two years were less likely to develop breast cancer than others who did not have a history of taking the drugs, a study released on Tuesday said.
Source: news.yahoo.com
Celebrex appears to prevent colon cancer
Researchers say they have found that high doses of the arthritis drug Celebrex reduced the number of pre-cancerous growths in the colon.
Source: www.news-medical.net
Key Events Involving Vioxx, Other Drugs
By The Associated Press Key events involving the safety of Vioxx and other painkillers: -December 1998: Food and Drug Administration approves Pfizer Inc.'s Celebrex, the first Cox-2 inhibitor, to treat arthritis.
Source: www.redorbit.com
Merck to pay $4.5M in Vio trial
A jury found Merck & Co. liable Wednesday for one of two former Vio users' heart attacks in a split verdict that awarded $4.5 million in damages to one of the plaintiffs.
Source: www.realcities.com
Celebrex promising, but raises heart risks
Is a drug that might lower the risk of colon cancer worth taking if it also raises the risk of heart problems? That's a question people most likely to develop the deadly bowel disease may be asking after the latest research on the popular arthritis drug Celebrex was released.
Source: www.grandforks.com
Jury splits verdict in two New Jersey Vioxx lawsuits
When the river rises Associated Press High School junior Lindsey Schultz and other volunteers fill sandbags in the small town of Hendrum, Minn., which is preparing for the rising floodwaters of the Red River and the Wild Rice River.
Source: www.uniontrib.com
Jury splits verdict in Vioxx lawsuits
ATLANTIC CITY, N.J. - A jury found Merck & Co. liable yesterday for one of two former Vioxx users' heart attacks in a split verdict that awarded $4.5 million in damages to one of the plaintiffs.
Source: www.telegram.com
Studies confirm celecoxib may help prevent colorectal cancer in high risk patients
WASHINGTON, D.C. During the past year, the study of the potential use of COX-2 (cyclooxygenase-2) inhibitors to prevent colorectal and breast cancer has come under intense scrutiny.
Source: www.eurekalert.org